Viking Therapeutics, Inc.'s VK2735 has potential as a GLP-1 for obesity amid Pfizer's exit, but competition and financing ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

With Semaglutide, postmenopausal women can achieve significant weight loss, improve insulin sensitivity, and lower the risk ...

Tirzepatide was associated with better glycemic control and weight loss outcomes than semaglutide and insulin among patients with T2D.

The legal battle over who can make and distribute a weight loss ingredient is brewing, and an Edmond telehealth provider is ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

Analysis is ongoing to compare differences in weight loss, lean mass, and fat mass reduction between those using tirzepatide and those using semaglutide. The researchers explained that their six ...

While weight loss medications can deliver significant results, our bodies eventually adapt to everything. And many people end ...

The market for anti-obesity drugs has been growing for a while, but is finally about to take off with the entry of two global ...

When it comes to managing weight loss ... medications such as semaglutide and tirzepatide. By December 2023, this percentage had increased to nearly 90%, with tirzepatide being the most commonly ...